How to screen non-viral gene delivery systems in vitro?

被引：96

作者：

van Gaal, Ethlinn V. B. ^{[1
]}

van Eijk, Roel ^{[1
]}

Oosting, Ronald S. ^{[2
]}

Kok, Robbert Jan ^{[1
]}

Hennink, Wim E. ^{[1
]}

Crommelin, Daan J. A. ^{[1
,3
]}

Mastrobattista, Enrico ^{[1
]}

机构：

[1] Univ Utrecht, UIPS, Dept Pharmaceut, NL-3584 CG Utrecht, Netherlands

[2] Univ Utrecht, UIPS, Dept Psychopharmacol, NL-3584 CG Utrecht, Netherlands

[3] Dutch Top Inst Pharma, Leiden, Netherlands

来源：

JOURNAL OF CONTROLLED RELEASE | 2011年 / 154卷 / 03期

关键词：

Gene delivery; Transfection; DNA; Particle size; Nanoparticles; pEI; DNA/TRANSFERRIN-PEI COMPLEXES; NUCLEAR-TARGETING SEQUENCE; PLASMID DNA; TRANSFECTION EFFICIENCY; LINEAR POLYETHYLENIMINE; SMOOTH-MUSCLE; INTRACELLULAR TRAFFICKING; REPORTER GENE; DEPENDENT INTERNALIZATION; MEDIATED TRANSFECTION;

D O I：

10.1016/j.jconrel.2011.05.001

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Screening of new gene delivery candidates regarding transfection efficiency and toxicity is usually performed by reading out transgene expression levels relative to a reference formulation after in vitro transfection. However, over the years and among different laboratories, this screening has been performed in a variety of cell lines, using a variety of conditions and read-out systems, and by comparison to a variety of reference formulations. This makes a direct comparison of results difficult, if not impossible. Reaching a consensus would enable placing new results into context of previous findings and estimate the overall contribution to the improvement of non-viral gene delivery. In this paper we illustrate the sensitivity of transfection outcomes on testing conditions chosen, and propose a screening protocol with the aim of standardization within the field. (C) 2011 Elsevier B.V. All rights reserved.

引用

页码：218 / 232

页数：15

共 183 条

[41] Advances in fluorescent tracking of nucleic acids in living cells [J].

Dirks, RW ;

Tanke, HJ .

BIOTECHNIQUES, 2006, 40 (04) :489-496

[42] Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors [J].

Douglas, Kimberly L. ;

Piccirillo, Ciriaco A. ;

Tabrizian, Maryam .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 68 (03) :676-687

[43] A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy [J].

Duguid, JG ;

Li, C ;

Shi, M ;

Logan, MJ ;

Alila, H ;

Rolland, A ;

Tomlinson, E ;

Sparrow, JT ;

Smith, LC .

BIOPHYSICAL JOURNAL, 1998, 74 (06) :2802-2814

[44]

Edwards B. S., 2007, Curr. Protoc. Cytom, V41, P9241, DOI [10.1002/0471142956.cy0924s41, DOI 10.1002/0471142956.CY0924S41]

[45] Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape [J].

El-Sayed, Ayman ;

Masuda, Tomoya ;

Khalil, Ikramy ;

Akita, Hidetaka ;

Harashima, Hideyoshi .

JOURNAL OF CONTROLLED RELEASE, 2009, 138 (02) :160-167

[46]

EMEA, 2001, NOT GUID QUAL PRECL

[47]

Erbacher P, 1999, J GENE MED, V1, P210

[48] Genuine DNA/polyethylenimine (PEI) complexes improve transfection properties and cell survival [J].

Erbacher, P ;

Bettinger, T ;

Brion, E ;

Coll, JL ;

Plank, C ;

Behr, JP ;

Remy, JS .

JOURNAL OF DRUG TARGETING, 2004, 12 (04) :223-236

[49] Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles [J].

Fogera, Florian ;

Noonpakdee, Wilai ;

Loretz, Brigitta ;

Joojuntr, Songwut ;

Salvenmoser, Willi ;

Thaler, Marlene ;

Bernkop-Schnurch, Andreas .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 319 (1-2) :139-146

[50] On the kinetics of polyplex endocytic trafficking: Implications for gene delivery vector design [J].

Forrest, ML ;

Pack, DW .

MOLECULAR THERAPY, 2002, 6 (01) :57-66

← 1 2 3 4 5 6 7 8 9 10 →